Lung cancer research has made quite a few headlines in the last couple of days and I have tried to compile a list that includes some interesting reads, as well as research that holds promise.
The research study finds that HIV infection increases chances of developing lung cancer by about 70%. The study was conducted by the US Department of Veterans Affairs and has been published online in the journal AIDS.
Hormone estrogen was found to promote lung cancer by compounding the effect of tobacco smoke. The new research was presented at the AACR Annual Meeting 2012 by Fox Chase Cancer Center, Philadelphia.
A new vaccine (Belagenpumatucel – L (Lucanix)) was found to increase survival rates in patients with non-progressive non-small cell lung cancer. Researchers found an increase of 50% in five-year survival rates in patients with moderately advanced cancer.
Men, who were on a targeted therapy for control of their lung cancers, experienced a significant drop in their testosterone levels. The study published in the journal Cancer, investigated the hormone levels in men with anaplastic lymphoma kinase (ALK) positive advanced non-small cell lung cancer, who were taking crizotinib.
According to a new study conducted by researchers at Moffitt Cancer Center, Tampa, Fla., lung cancer patients experience increased depression due to social rejection, social isolation, and internalized shame. This is the first study of its kind that examines perceived stigma and depressive symptomology in patients with lung cancer. The study has since been published in the journal Psycho-Oncology.